All stock lists
HCA Healthcare, Inc. (New York Stock Exchange:HCA)
US · Delayed Price · Currency is USD
Healthcare · Medical - Care Facilities
469.03+1.72 (+0.37%)
Insider Score
––Not scored
HCA Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
HCA analyst forecast
HCA analyst consensus
No analyst ratings in the last 3 months.
HCA 12-month price target
$490.71+5.2% upsideaverage of 7 firms
$551.00High
$369.00Low
Best analysts covering HCA
No firm covering HCA has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
HCA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Oppenheimer | — | $485.00 | +24.7% | — | 2026-07-27 | |
| Wells Fargo | — | $369.00 | -0.6% | — | 2026-07-20 | |
| Raymond James | — | $528.00 | +24.3% | — | 2026-07-07 | |
| Barclays | — | $551.00 | +8.9% | — | 2026-01-28 | |
| Wells Fargo | — | $452.00 | -6.5% | — | 2026-01-07 | |
| Stephens | — | $500.00 | +11.8% | — | 2025-10-27 | |
| RBC Capital | — | $482.00 | +7.8% | — | 2025-10-27 | |
| Goldman Sachs | — | $520.00 | +15.0% | — | 2025-10-27 | |
| Raymond James | — | $525.00 | +15.5% | — | 2025-10-27 | |
| RBC Capital | — | $401.00 | +20.0% | — | 2025-07-28 | |
| Morgan Stanley | — | $410.00 | +9.9% | — | 2025-06-09 | |
| Barclays | — | $416.00 | +8.9% | — | 2025-06-02 | |
| KeyBanc | — | $370.00 | +20.0% | — | 2025-01-07 | |
| Oppenheimer | — | $400.00 | +11.4% | — | 2024-10-28 | |
| KeyBanc | — | $420.00 | +17.0% | — | 2024-10-28 | |
| Mizuho Securities | — | $425.00 | +18.3% | — | 2024-10-28 | |
| KeyBanc | — | $475.00 | +22.7% | — | 2024-10-10 | |
| Deutsche Bank | — | $441.00 | +8.6% | — | 2024-10-01 | |
| Truist Financial | — | $430.00 | +15.0% | — | 2024-08-19 | |
| Deutsche Bank | — | $375.00 | +11.9% | — | 2024-06-28 | |
| Jefferies | — | $390.00 | +15.8% | — | 2024-06-06 | |
| RBC Capital | — | $329.00 | +5.8% | — | 2024-04-29 | |
| Oppenheimer | — | $345.00 | +12.5% | — | 2024-04-29 | |
| Deutsche Bank | — | $359.00 | +9.7% | — | 2024-04-12 | |
| Mizuho Securities | — | $298.00 | +4.2% | — | 2023-04-24 | |
| Oppenheimer | — | $310.00 | +8.4% | — | 2023-04-24 | |
| RBC Capital | — | $315.00 | +10.2% | — | 2023-04-24 | |
| Mizuho Securities | — | $230.00 | +7.7% | — | 2022-08-16 | |
| Loop Capital Markets | — | $240.00 | +39.9% | — | 2022-06-16 | |
| BMO Capital | — | $240.00 | +9.6% | — | 2022-04-28 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.